Friday, July 18, 2014

Best Stock Investments For 2014

With shares of Honda Motor (NYSE:HMC) trading around $38, is HMC an OUTPERFORM, WAIT AND SEE or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:

T = Trends for a Stock’s Movement

Honda Motor develops, produces, and manufactures a variety of motor products ranging from small general-purpose engines and scooters to specialty sports cars. The company�� business segments are the motorcycle business, automobile business, financial services business, and power product and other businesses. Honda conducts its operations in Japan and worldwide, including North America, Europe, and Asia.

Honda Motor may be floating $2.75 billion worth of U.S. dollar-denominated bonds in three parts as soon as Friday, sources told The Detroit News. Honda�� finance division could release $1.75 billion of three-year debt, made up of $1 billion of fixed-rate notes yielding 65 basis points more than similar-maturity Treasuries, as well as $750 million of floating-rate securities paying 50 basis points more than the three-month London interbank offered rate, the sources said.

Hot Regional Bank Companies To Watch In Right Now: Northern Financial Corp (NFC)

Northern Financial Corporation (Northern) is engaged in full service investment dealer business, through its wholly owned subsidiary, Northern Securities Inc. (Northern Securities), providing financial advisory services to retail and institutional clients and investment banking services to small capitalization companies. The Company�� business generates revenue from commissions and advisory fees earned on investment banking activities, and commissions from institutional sales and trading and retail investment advisors, and from principal trading. Northern is also engaged in merchant banking business that supplements the investment dealer business. Northern Securities is a member firm of the Investment Industry Regulatory Organization of Canada (IIROC). Advisors' Opinion:
  • [By Holly LaFon]

    Several financial institutions and credit card companies along with companies like Google, Inc. (GOOG), Apple, Inc. (AAPL), and Paypal have aspirations to be players in the emerging sector of mobile payments. Mobile payments allow you to pay for goods or service from your phone instead of paying with cash, check, or credit cards. Today, these payment mechanisms are restricted to premium SMS, direct carrier billing, website purchases through a mobile browser, and Near Field Communications (NFC). NFC is a set of standards for smartphones and similar devices that allow them to communicate with each other without touching, but by being in close proximity. NFC devices can be used in contactless payment systems, similar to those used in credit cards, to allow mobile payment to replace or supplement existing credit card and debit card type systems. The combined market for all types of mobile payments is expected to reach more than $600 billion globally by 2013. Google, Inc., a Baron investment, is currently the only company that has a large commercial NFC deployment in the market today. As Google pushes further into local advertising and promotions, it plans to utilize Google Wallet to enhance its relationship with consumers and businesses. Google Wallet is a mobile payment system developed by Google that allows smartphone users to store credit cards, loyalty card, and gift cards on their mobile phones, utilizing NFC for the payment of goods and services. Consumers will be able to redeem promotions or loyalty programs through Google Wallet, enabling stores to enhance their relationships with consumers.

Best Stock Investments For 2014: Bayer AG (BAYRY.PK)

Bayer AG is a management holding company. The Company�� business operations are organized into three subgroups: HealthCare, CropScience and MaterialScience, supported by the service companies Bayer Business Services, Bayer Technology Services and Currenta. Bayer HealthCare is involved in the research, development and manufacture of health products for people and animals. Bayer CropScience is engaged in the crop protection and non-agricultural pest control. Bayer MaterialScience supplies polymers, and develops solution for a range of applications. In November 2009, Bayer MaterialScience acquired the polymer coatings business from Lombard Medical Technologies PLC. On November 2, 2009, it acquired Athenix Corporation. On October 1, 2009, it acquired two dermatology product lines from SkinMedica, Inc., Carlsbad, California, United States. On June 25, 2009, it acquired the remaining 10% interest in Bayer Polymers (Shanghai) Co. Ltd., China. In May 2009, it acquired the remaining 49% interest in Berlimed, s.a., Spain, from Juste s.a. Quimica Farmac茅utica (Juste), and in return sold its 51% interest of Justesa Imagen, s.a., Spain, to Juste. In May 2009, it also sold the Thermoplastics Testing Center, Krefeld, Germany, to Underwriters Laboratories Inc. In March 2010, the Company announced that its Bayer MaterialScience LLC has acquired Artificial Muscle, Inc, a company active in electroactive polymers for the consumer electronics industry.

Bayer HealthCare

The Company researches, develops, manufactures pharmaceutical and medical products. Bayer HealthCare operates in four operating divisions: Animal Health, which is engaged in manufacture of veterinary medicines and grooming products; Bayer Schering Pharma, which is engaged in manufacture of prescription medicines; Consumer Care, which is engaged in the manufacture of over-the-counter medicines and dietary supplements, and Medical Care, which is engaged in manufacture of blood glucose monitoring devices and contrast agent injecti! on systems. Its products for farm animals include Baytril. Its products for companion animals include Advantage/Advantix and Baytril. Its drug discovery in the pharmaceuticals segment focuses on the areas of cardiology, oncology,

women�� healthcare and diagnostic imaging.

Bayer CropScience

CropScience maintains a global network of research and development facilities. In the Crop Protection segment it identifies and develops safe and economically sustainable insecticides, fungicides and herbicides and carries its research projects in areas, such as plant health or stress tolerance. As of December 31, 2009, its active ingredient pipeline of Crop Protection contained 20 development projects, of which 10 was at an advanced stage and 10 at an early stage of development, and an additional 45 projects was undergoing early-stage research. Its operations are structured into six business operations units: four regional Crop Protection units plus the Environmental Science and BioScience units. Its insecticides include Confidor/ Admire, Calypso, Decis, Temik and Oberon. Its fungicides include Antracol, Fandango, Flint/Stratego/Sphere/Twist, Folicur and Previcur Energy. Its herbicides include Atlantis, Basta, Betanal, Fenikan, Hoestar, Husar, MaisTer, Puma. Its seed treatment products include Bariton, Gaucho, Lamarador, Poncho and Raxil.

Bayer MaterialScience

The Company supplies materials, such as polycarbonates and polyurethanes and system solutions for a range of everyday uses. It operates in three business units: Polyurethanes, Polycarbonates, and Coatings, Adhesives and Specialties. Its Coatings, Adhesives, Specialties producst include Desmodur, Bayhydur, Dispercoll and Artwalk. Its Polycarbonates include Makrolon, Makrofol / Bayfol, Fantasia and Bayblend. Its Polyurethanes include Multitec, Baydur, Bayflex, Baypreg and Vulkollan. Its Thermoplastic Polyurethanes include Desmopan / Texin.

Advisors' Opinion:
  • [By Bioassociate Consulting]

    KYTH holds a collaboration agreement with Bayer's (BAYRY.PK) dermatology division to develop and commercialize ATX-101 outside the United States and Canada, and is eligible to receive up to $297m in additional regulatory and commercialization milestones, as well as escalating sales royalties in mid to high-teens. Bayer completed two pivotal Phase III trials of ATX-101 in Europe for the reduction of submental fat. During June 2012, Kythera released results from these studies, in which ATX-101 achieved a statistically significant reduction in submental fat based on clinician, patient and objective ratings.

  • [By Henry Kawabe]

    In June, Seattle Genetics announced it entered into a collaboration with Bayer HealthCare (BAYRY.PK) for access to its Seattle Genetics' auristatin-based ADC technology to create cancer drugs that home in on tumors and then deliver a toxic dose to their cells. The collaboration will generate upfront and option exercise fees of up to $20 million. Seattle Genetics is also eligible to receive up to approximately $500 million in potential milestone payments, as well as royalties on worldwide net sales of any resulting products under the multi-target collaboration.

Best Stock Investments For 2014: MAKO Surgical Corp.(MAKO)

MAKO Surgical Corp., a medical device company, markets its advanced robotic arm solution and orthopedic implants for orthopedic procedures in the United States and internationally. The company offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specific osteoarthritic disease. It also provides robotic arm interactive orthopedic system (RIO) consisting of a tactile robotic arm utilizing an integrated bone cutting instrument; and a patient specific visualization component, which offers pre-operative and intra-operative guidance to the orthopedic surgeon, enabling tissue sparing bone removal, and accurate implant insertion and alignment. The company?s MAKOplasty partial knee arthroplasty solution enables resurfacing of one or two specific diseased compartments of the joint, preserving more soft tissue and healthy bone of the knee; and MAKOplasty Total Hip Arthroplasty, a surgical solution that enables orthopedic surgeons to pe rform total hip arthroplasty. In addition, it offers tactile guidance system, which allows orthopedic surgeons to treat degenerative knee osteoarthritis from early-stage unicompartmental degeneration through mid-stage multicompartmental degeneration with a modular knee implant system; and RESTORIS family of implants for use in single and bicompartmental knee resurfacing procedures. The company markets its products through direct sales force, as well as through independent orthopedic product agents and distributors. MAKO Surgical Corp. was founded in 2004 and is headquartered in Fort Lauderdale, Florida.

Advisors' Opinion:
  • [By Alex Planes]

    Intuitive Surgical's stock has been battered by worse-than-expected third-quarter results, which included the first year-over-year quarterly revenue decline in company history, coming on the heels of an underwhelming second quarter this summer. Fool contributor Rupert Hargreaves notes that the FDA's initiated an investigation on Intuitive's da Vinci surgical robotics systems, after it found several discrepancies in its incident reports. As a result, quarterly sales of the da Vinci declined from 155 units to 101 units, a drop that can only be partly blamed on slowing demand for medical devices in the U.S. Intuitive may have underperformed compared to recently acquired MAKO Surgical (NASDAQ: MAKO  ) and Accuray (NASDAQ: ARAY  ) over the past year, but it remains the 800-pound gorilla among these industry peers.

  • [By Dan Burrows]

    A 2.3% sales tax is indeed tough to swallow. Even an unprofitable medical device company like Mako Surgical (MAKO) — which recently was bought by Stryker (SYK) — would have to pay the tax. Eesh.

  • [By Dan Caplinger]

    Competition in robotic surgical devices is also starting to get fiercer. MAKO Surgical (NASDAQ: MAKO  ) recently filed lawsuits against rivals Blue Belt Technologies and Stanmore Implants, with allegations of improper conduct by a former sales manager in the case of Blue Belt and of patent infringement against Stanmore. Just today, Stanmore gave in to most of MAKO's demands, deciding to give up its robotics business and sell its related assets to MAKO to settle the dispute. As for Intuitive, it hasn't yet seen a major direct competitive threat, but if the da Vinci gets past current safety concerns, growing popularity could drive big industry players to look at coming up with robotic systems of their own.

  • [By Jake L'Ecuyer]

    Equities Trading UP
    MAKO Surgical (NASDAQ: MAKO) shot up 82.38 percent to $29.49 after the company agreed to be acquired by Stryker (NYSE: SYK) for $30 per share in cash. Shares of Ascena Retail Group (NASDAQ: ASNA) got a boost, shooting up 16.34 percent to $20.17 after the company reported upbeat fiscal fourth-quarter results.

Best Stock Investments For 2014: Computer Task Group Inc (CTG)

Computer Task Group, Incorporated (CTG), incorporated on March 11, 1966, is an information technology (IT) solutions and staffing company with operations in North America and Europe. CTG provides IT services to its clients, which includes IT Solutions and IT Staffing. During the year ended December 31, 2011, the Company had six operating subsidiaries: Computer Task Group of Canada, Inc., providing services in Canada; and Computer Task Group Belgium N.V., CTG ITS S.A., Computer Task Group IT Solutions, S.A., Computer Task Group Luxembourg PSF, and Computer Task Group (U.K.) Ltd., each were providing services in Europe. Services provided in North America are performed by CTG. It provides services to all of the markets, which it serves. The services provided encompass the IT business solution life cycle, including phases for planning, developing, implementing, managing, and maintaining the IT solution. In February 2013, it acquired etrinity from i-Cros Nv of Antwerp, Belgium.

The Company promotes its services through four vertical market focus areas: technology service providers; healthcare, which includes services provided to healthcare providers, health insurers (payers), and life sciences companies; energy, and financial services. At December 31, 2011, CTG provided IT services to approximately 300 clients in North America and Europe. In North America, the Company operates in the United States and Canada. In Europe, the Company operates in Belgium, Luxembourg, and the United Kingdom.

IT Solutions

CTG�� services in IT solution area include helping clients assess their business needs and identifying the IT solutions. The services delivered by the Company include the selection and implementation of packaged software and the design, development, testing, and integration of new systems, and the development and implementation of customized software and solutions designed to fit the needs of a specific client or vertical market. Also included in IT Solutions is Trans! itional Application Management (TAM).

In 2011, the healthcare market accounted for most of CTG�� TAM business. In 2011, CTG continued to invest in new IT solutions development, primarily targeted to the healthcare market, which support cost reductions and productivity improvements. In 2011, several healthcare solutions under development moved from the pilot stage of testing using live data into the sales process as completed tools. These solutions include medical fraud, waste, and abuse detection and reduction, medical care and disease management, and group insurance underwriting risk assessment. The Company has developed software to support these offerings. These solutions support both the healthcare provider and payer markets.

IT Staffing

The Company recruits, retains, and manages IT talent for its clients, which are technology service providers and companies with multiple locations and need for external IT resources. The Company also supports companies and organizations that need to augment their own IT staff on a flexible basis. It provides IT talent services on a temporary or long-term basis. CTG�� recruiting organization works with customers to define their staffing requirements. The primary focus of the Company�� staffing business is a managed services model that provides clients with support through supply models customized to client needs, resource management support, vendor management programs, and a automated recruiting process and system. During 2011, its IT staffing service generated 63% of its total revenue.

Advisors' Opinion:
  • [By Anna Prior]

    Information technology staffing and solutions company Computer Task Group Inc.(CTG) cut its outlook for its second-quarter and full-year results, primarily due to higher medical costs.

Best Stock Investments For 2014: Hastings Entertainment Inc.(HAST)

Hastings Entertainment, Inc. operates as a multimedia entertainment retailer. It operates entertainment superstores that buy, sell, trade, and rent various home entertainment products, including books, music, software, periodicals, movies on DVD and Blu-Ray, video games, video game consoles and consumer electronics. The company?s stores also provide consumables and trends products, such as apparel, t-shirts, action figures, posters, greeting cards, and seasonal merchandise. As of March 31, 2011, it operated 145 superstores in medium-sized markets located in 20 states, primarily in the western and midwestern United States. The company also operates a concept store, Sun Adventure Sports that sells a range of bicycles and related accessories, skateboards, other athletic equipment, apparel, and shoes, as well as offers bicycle repair services and cycling classes. In addition, it operates a multimedia entertainment e-commerce Web site, which offers a range of books, software, video games, movies on DVDs and Blu-Ray, music, trends, and electronics. The company was founded in 1968 and is headquartered in Amarillo, Texas.

Advisors' Opinion:
  • [By James E. Brumley]

    At first glance it would be easy to assume the recent bullishness from Hastings Entertainment, Inc. (NASDAQ:HAST) was nothing more than a little volatility, as is common for many small cap stocks. After all, HAST shares have been beaten down pretty well since the middle of last year, and a little bit of "up" relief is likely in the cards. As it turns out, however, the current reversal we're seeing from this stock may be a far bigger - and a far longer lasting - turnaround than traders may realize with just a quick look.

Best Stock Investments For 2014: MGIC Investment Corp (MTG)

MGIC Investment Corporation (MGIC), incorporated June 21, 1984, is a holding company and through wholly owned subsidiaries is a private mortgage insurer in the United States. As of December 31, 2012, its principal mortgage insurance subsidiaries, Mortgage Guaranty Insurance Corporation (MGIC) and MGIC Indemnity Corporation (MIC), were each licensed in all 50 states of the United States, the District of Columbia and Puerto Rico. During the year ending December 31, 2012, the Company wrote new insurance in each of those jurisdictions in MGIC and/or MIC. The Company capitalized MIC to write new insurance in certain jurisdictions where MGIC no longer meets, and is unable to obtain a waiver of, those jurisdictions��minimum capital requirements. Private mortgage insurance covers losses from homeowner defaults on residential mortgage loans, reducing and, in some instances, eliminating the loss to the insured institution if the homeowner defaults.

Mortgage Insurance

Primary insurance provides mortgage default protection on individual loans and covers unpaid loan principal, delinquent interest and certain expenses associated with the default and subsequent foreclosure. Primary insurance is written on first mortgage loans secured by owner occupied single-family homes, which are one-to-four family homes and condominiums. Primary insurance is also written on first liens secured by non-owner occupied single-family homes, which are referred to in the home mortgage lending industry as investor loans, and on vacation or second homes. Primary coverage can be used on any type of residential mortgage loan instrument approved by the mortgage insurer.

When a borrower refinances a mortgage loan insured by the Company by paying it off in full with the proceeds of a new mortgage that is also insured by it, the insurance on that existing mortgage is cancelled, and insurance on the new mortgage is considered to be new primary insurance written. Therefore, continuation of its coverage fr! om a refinanced loan to a new loan results in both a cancellation of insurance and new insurance written. When a lender and borrower modify a loan rather than replace it with a new one, or enter into a new loan pursuant to a loan modification program, its insurance continues without being cancelled assuming that the Company consent to the modification or new loan.

The borrower�� mortgage loan instrument requires the borrower to pay the mortgage insurance premium. There are several payment plans available to the borrower, or lender, as the case may be. Under the monthly premium plan, the borrower or lender pays it a monthly premium payment to provide only one month of coverage. Under the annual premium plan, an annual premium is paid to it in advance, and it earns and recognizes the premium over the next 12 months of coverage, with annual renewal premiums paid in advance thereafter and earned over the subsequent 12 months of coverage. Under the single premium plan, the borrower or lender pays it a single payment covering a specified term exceeding twelve months.

Pool insurance is used as an additional credit enhancement for certain secondary market mortgage transactions. Pool insurance covers the excess of the loss on a defaulted mortgage loan which exceeds the claim payment under the primary coverage, if primary insurance is required on that mortgage loan, as well as the total loss on a defaulted mortgage loan which did not require primary insurance. Pool insurance is used as an additional credit enhancement for certain secondary market mortgage transactions. Pool insurance covers the excess of the loss on a defaulted mortgage loan, which exceeds the claim payment under the primary coverage, if primary insurance is required on that mortgage loan, as well as the total loss on a defaulted mortgage loan which did not require primary insurance. In general, the loans insured by it in Wall Street bulk transactions consisted of loans with reduced underwriting documentation; cash out! refinanc! es, which exceed the standard underwriting requirements of the Federal National Mortgage Association (Fannie Mae) and Federal Home Loan Mortgage Corporation (Freddie Mac) (collectively GSEs); A- loans; subprime loans, and jumbo loans.

Other Products and Services

The Company has participated in risk sharing arrangements with the GSEs and captive mortgage reinsurance arrangements with subsidiaries of certain mortgage lenders, which reinsure a portion of the risk on loans originated or serviced by the lenders, which have MGIC primary insurance. It provides information regarding captive mortgage reinsurance arrangements to the New York Department of Insurance (known as the New York Department of Financial Services), the Minnesota Department of Commerce and the Department of Housing and Urban Development, (HUD). It performs contract underwriting services for lenders, in which it judges whether the data relating to the borrower and the loan contained in the lender�� mortgage loan application file comply with the lender�� loan underwriting guidelines. It also provides an interface to submit data to the automated underwriting systems of the GSEs, which independently judge the data. These services are provided for loans, which require private mortgage insurance, as well as for loans that do not require private mortgage insurance. It provides mortgage services for the mortgage finance industry, such as portfolio retention and secondary marketing of mortgages.

The Company competes with Federal Housing Administration, Veterans Administration, PMI Mortgage Insurance Company, Genworth Mortgage Insurance Corporation, United Guaranty Residential Insurance Company, Radian Guaranty Inc., CMG Mortgage Insurance Company, and Essent Guaranty, Inc.

Advisors' Opinion:
  • [By Lisa Levin]

    MGIC Investment (NYSE: MTG) shares dropped 11.47% to $8.18 following FHFA proposal. The company released monthly operating statistics for June.

    Rent-A-Center (NASDAQ: RCII) shares slipped 10.98% to $25.87 after the company issued a downbeat guidance for the second quarter. The company expected adjusted earnings of $0.36 to $0.38 per share on revenue of around $773 million.

  • [By Jon C. Ogg]

    MGIC Investment Corp. (NYSE: MTG) made the move to the Conviction Buy List on December 5, with a $10 price target. The company is benefiting from a solid improvement in credit and mortgage quality. With shares close to $8.40 now, the consensus price target is $8.81 and the 52-week trading range is $1.92 to $8.59. We noticed that the $10 price target is well under the street-high target of $13 on this stock.

  • [By Ben Levisohn]

    MGIC Investment (MTG) was not to supposed to turn a profit during the quarter. If the analysts were right, the mortgage insurer’s second-quarter profit was supposed to be a blip and MGIC would return to its money-losing ways.

    Associated Press

    That’s not quite what happened. MGIC reported a profit of 4 cents a share versus forecasts for a loss of 10 cents, according to FactSet and MGIC’s shares popped 14% to $8.29.

    Its big day has also boosted other insurers. Radian Group (RDN) has risen 7.2% to $14.39, while Old Republic International (ORI) has advanced 2.1% to $15.24, Genworth Financial (GNW) is up 3.6% at $13.41 and MBIA Inc. (MBI) has jumped 4.3% to $10.76.

    Susquehanna’s Jack Micenko credits a better economy with boosting earnings:

    The beat was driven by lower loss reserving – $180 mln versus our estimate of $225 and the consensus estimate of $240, as favorable economic trends helped drive their default book claim rate and severity lower…

    Micenko expects MGIC’s shares to hit $13, a 57% gain from its current price.

  • [By Garrett Cook]

    In trading on Friday, financial shares were relative laggards, down on the day by about 0.40 percent. Top losers in the sector included MGIC Investment (NYSE: MTG), down 11.9 percent, and Radian Group (NYSE: RDN), off 5.2 percent.

No comments:

Post a Comment